AWP1 Biomarker composition for diagnosing cancer metastasis comprising AWP1

摘要

The present invention relates to a biomarker composition for the diagnosis of cancer metastasis comprising AWP1, and it can be used as a clinical indicator for cancer metastasis by confirming that the expression of AWP1 is reduced in a cancer which is more easily metastasized than a non-metastatic cancer. In addition, it was confirmed that the inhibition of AWP1 expression by siRNA increased cancer growth and metastasis, and it was confirmed that when overexpression of AWP1 inhibited cancer metastasis by reducing cancer growth and migration, AWP1 could be used as a cancer metastasis inhibitor have.